These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8553686)

  • 1. A cytochrome P4502B form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea pig.
    Chung WG; Miranda CL; Buhler DR
    Xenobiotica; 1995 Sep; 25(9):929-39. PubMed ID: 8553686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues.
    Miranda CL; Chung W; Reed RE; Zhao X; Henderson MC; Wang JL; Williams DE; Buhler DR
    Biochem Biophys Res Commun; 1991 Jul; 178(2):546-52. PubMed ID: 1907134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
    Chung WG; Buhler DR
    Drug Metab Dispos; 1995 Nov; 23(11):1263-7. PubMed ID: 8591728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver.
    Miranda CL; Reed RL; Guengerich FP; Buhler DR
    Carcinogenesis; 1991 Mar; 12(3):515-9. PubMed ID: 2009596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in the hepatic microsomal metabolism of the pyrrolizidine alkaloid senecionine.
    Winter CK; Segall HJ; Jones AD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):429-33. PubMed ID: 2903002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle.
    Duringer JM; Buhler DR; Craig AM
    Am J Vet Res; 2004 Nov; 65(11):1563-72. PubMed ID: 15566096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of the pyrrolizidine alkaloid, senecionine, in Fischer 344 and Sprague-Dawley rats.
    Chung WG; Buhler DR
    Arch Pharm Res; 2004 May; 27(5):547-53. PubMed ID: 15202562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine.
    Reed RL; Miranda CL; Kedzierski B; Henderson MC; Buhler DR
    Xenobiotica; 1992 Nov; 22(11):1321-7. PubMed ID: 1492424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a newly identified isoform of cytochrome P450 responsible for 3-hydroxylation of 2,5,2',5'-tetrachlorobiphenyl in hamster liver.
    Koga N; Kikuichi-Nishimura N; Hara T; Harada N; Ishii Y; Yamada H; Oguri K; Yoshimura H
    Arch Biochem Biophys; 1995 Mar; 317(2):464-70. PubMed ID: 7893164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical characterization of a cytochrome P450 isozyme and a protein purified from liver microsomes of male guinea pigs and their roles in the oxidative metabolism of delta 9-tetrahydrocannabinol by guinea pig liver microsomes.
    Narimatsu S; Akutsu Y; Matsunaga T; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1992 Apr; 43(8):1729-36. PubMed ID: 1315542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine.
    Lin G; Cui YY; Liu XQ; Wang ZT
    Chem Res Toxicol; 2002 Nov; 15(11):1421-8. PubMed ID: 12437333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.
    Poet TS; McQueen CA; Halpert JR
    Drug Metab Dispos; 1996 Jan; 24(1):74-80. PubMed ID: 8825193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P-450-dependent nicotine oxidation by liver microsomes of guinea pigs. Immunochemical evidence with antibody against phenobarbital-inducible cytochrome P-450.
    Nakayama H; Nakashima T; Kurogochi Y
    Biochem Pharmacol; 1985 Jul; 34(13):2281-6. PubMed ID: 4015676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.